Literature DB >> 31578704

Opioid-Induced Tolerance and Hyperalgesia.

Sebastiano Mercadante1,2, Edoardo Arcuri3, Angela Santoni4.   

Abstract

Opioids are very potent and efficacious drugs, traditionally used for both acute and chronic pain conditions. However, the use of opioids is frequently associated with the occurrence of adverse effects or clinical problems. Other than adverse effects and dependence, the development of tolerance is a significant problem, as it requires increased opioid drug doses to achieve the same effect. Mechanisms of opioid tolerance include drug-induced adaptations or allostatic changes at the cellular, circuitry, and system levels. Dose escalation in long-term opioid therapy might cause opioid-induced hyperalgesia (OIH), which is a state of hypersensitivity to painful stimuli associated with opioid therapy, resulting in exacerbation of pain sensation rather than relief of pain. Various strategies may provide extra-opioid analgesia. There are drugs that may produce independent analgesic effects. A tailored treatment provided by skilled personnel, in accordance with the individual condition, is mandatory. Any treatment aimed at reducing opioid consumption may be indicated in these circumstances. Interventional techniques able to decrease the pain input may allow a decrease in the opioid dose, thus reverting the mechanisms producing tolerance of OIH. Intrathecal therapy with local anesthetics and a sympathetic block are the most common techniques utilized in these circumstances.

Entities:  

Year:  2019        PMID: 31578704     DOI: 10.1007/s40263-019-00660-0

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  112 in total

Review 1.  Glia: novel counter-regulators of opioid analgesia.

Authors:  Linda R Watkins; Mark R Hutchinson; Ian N Johnston; Steven F Maier
Journal:  Trends Neurosci       Date:  2005-10-24       Impact factor: 13.837

2.  Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.

Authors:  Tatsuya Hashimoto; Yoji Saito; Kazuo Yamada; Nobumasa Hara; Yumiko Kirihara; Mikako Tsuchiya
Journal:  Anesthesiology       Date:  2006-09       Impact factor: 7.892

Review 3.  Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness.

Authors:  S Mercadante; R K Portenoy
Journal:  J Pain Symptom Manage       Date:  2001-04       Impact factor: 3.612

4.  Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.

Authors:  Michael M Morgan; Erin N Bobeck; Susan L Ingram
Journal:  Brain Res       Date:  2009-08-05       Impact factor: 3.252

5.  Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance.

Authors:  Joshua W Little; Salvatore Cuzzocrea; Leesa Bryant; Emanuela Esposito; Timothy Doyle; Smita Rausaria; William L Neumann; Daniela Salvemini
Journal:  Pain       Date:  2013-02-27       Impact factor: 6.961

6.  The use of ketamine in a palliative-supportive care unit: a retrospective analysis.

Authors:  Sebastiano Mercadante; Amanda Caruselli; Alessandra Casuccio
Journal:  Ann Palliat Med       Date:  2018-04

7.  Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).

Authors:  Mark R Hutchinson; Susannah S Lewis; Benjamen D Coats; David A Skyba; Nicole Y Crysdale; Debra L Berkelhammer; Anita Brzeski; Alexis Northcutt; Christine M Vietz; Charles M Judd; Steven F Maier; Linda R Watkins; Kirk W Johnson
Journal:  Brain Behav Immun       Date:  2008-10-04       Impact factor: 7.217

8.  β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.

Authors:  M Connor; E E Bagley; B C Chieng; M J Christie
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons.

Authors:  Ning Zhang; Thomas J Rogers; Michael Caterina; Joost J Oppenheim
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

Review 10.  Cancer-Related Neuropathic Pain.

Authors:  Helen L Edwards; Matthew R Mulvey; Michael I Bennett
Journal:  Cancers (Basel)       Date:  2019-03-16       Impact factor: 6.639

View more
  29 in total

1.  An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects.

Authors:  Long Zhao; Hao Luo; Yu Ma; Shengze Zhu; Yongjiang Wu; Muxing Lu; Xiaojun Yao; Xin Liu; Gang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-25       Impact factor: 12.779

Review 2.  Opioid Use Consequences, Governmental Strategies, and Alternative Pain Control Techniques Following Total Hip Arthroplasties.

Authors:  Kevin Berardino; Austin H Carroll; Daniel Popovsky; Robert Ricotti; Matthew D Civilette; William F Sherman; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-05-31

Review 3.  Cancer Pain Treatment Strategies in Patients with Cancer.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2022-09-21       Impact factor: 11.431

4.  Opioid-Induced Hyperalgesic Priming in Single Nociceptors.

Authors:  Eugen V Khomula; Dionéia Araldi; Ivan J M Bonet; Jon D Levine
Journal:  J Neurosci       Date:  2020-11-17       Impact factor: 6.167

5.  Mechanisms, diagnosis, prevention and management of perioperative opioid-induced hyperalgesia.

Authors:  Sylvia H Wilson; Kevin M Hellman; Dominika James; Adam C Adler; Arvind Chandrakantan
Journal:  Pain Manag       Date:  2021-03-29

6.  Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice.

Authors:  Ming Tatt Lee; Yi-Hung Chen; Ken Mackie; Lih-Chu Chiou
Journal:  J Pain       Date:  2020-10-15       Impact factor: 5.820

Review 7.  Practical Advices for Treating Chronic Pain in the Time of COVID-19: A Narrative Review Focusing on Interventional Techniques.

Authors:  Giuliano Lo Bianco; Alfonso Papa; Michael E Schatman; Andrea Tinnirello; Gaetano Terranova; Matteo Luigi Giuseppe Leoni; Hannah Shapiro; Sebastiano Mercadante
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

8.  Efficacy and safety of acupuncture combined with analgesics on lung cancer pain: A protocol for systematic review and meta-analysis.

Authors:  Renqing Kuang; Guojiang Xiong; Wei Lv; Yun Zhao; Min Yu; Jiawang Jiang
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

9.  Spinal A3 adenosine receptor activation acutely restores morphine antinociception in opioid tolerant male rats.

Authors:  Heather Leduc-Pessah; Cynthia Xu; Churmy Y Fan; Rebecca Dalgarno; Yuta Kohro; Sydney Sparanese; Nikita N Burke; Kenneth A Jacobson; Christophe Altier; Daniela Salvemini; Tuan Trang
Journal:  J Neurosci Res       Date:  2021-06-01       Impact factor: 4.433

10.  The Moderating Role of Fatigue Sensitivity in the Relation between Depression and Alcohol and Opioid Misuse among Adults with Chronic Low Back Pain.

Authors:  Kara Manning; Andrew H Rogers; Lorra Garey; Michael J Zvolensky
Journal:  Fatigue       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.